Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation.
about
Brain-gut-microbiota axis in Parkinson's diseaseParallel manifestations of neuropathologies in the enteric and central nervous systemsNeurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's diseaseCalcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease.Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.The management of gastrointestinal symptoms in Parkinson's disease.Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.Restoration of intestinal function in an MPTP model of Parkinson's Disease.Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.Controlled-protein dietary regimens for Parkinson's disease.Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.Functions of the nigrostriatal dopaminergic synapse and the use of neurotransplantation in Parkinson's disease.How might physical activity benefit patients with Parkinson disease?The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations.Vagally-mediated effects of brainstem dopamine on gastric tone and phasic contractions of the rat.Vagal neurocircuitry and its influence on gastric motilityNeurotransmitters: The Critical Modulators Regulating Gut-Brain Axis.Enteric co-innervation of striated muscle in the esophagus: still enigmatic?Accumulation of Alpha-synuclein Causes Colonic Dysmotility Independently of Enteric Nervous Damage in the Early Stage of Parkinson's Disease (Neurogastroenterol Motil 2012;24:e425-e436).Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease.Beneficial Effect of Vitamin E in Rotenone Induced Model of PD: Behavioural, Neurochemical and Biochemical Study.α-Synuclein in gut endocrine cells and its implications for Parkinson's diseaseNeuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.Early recognition of pelvic floor dyssynergia and colorectal assessment in Parkinson's disease associated with bowel dysfunction.Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease?The Universal Non-Neuronal Nature of Parkinson's Disease: A Theory.Parkinson's Disease from the Gut.A Nigro-Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism.Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro.
P2860
Q26784403-029198FE-19A1-44DB-9802-F8EDE1A379FCQ26823182-346DB258-0DC0-4B59-9459-7E56BA3CACCDQ27012533-2A5CF506-21F6-4EA9-AE31-64E558E4D71EQ30525353-24519284-F5D3-47BD-AE6E-24AEB0974A94Q33773655-26CF1F94-CAEC-460A-B4F6-B3C7ECECBB47Q34250597-848CC0D4-99A1-4C6E-85E8-0E95D713D179Q35917625-E4591E94-8D18-4BF6-B094-BC24C16BEF5BQ36896034-EB84E34A-F101-43A8-99F1-3BEDC739F035Q37137476-AE5DC6DE-DE1F-4077-8A3E-276E06D07396Q37386416-82F10735-384D-4A7C-81F0-B980DA7ED7DFQ37687536-63AEDAA8-D6E9-4822-9336-E57D703A1CABQ37791469-49B4AF04-E9B0-487E-82C1-53E84D746D0EQ37872232-4E65FDBF-4EA0-4495-880B-B0892A9B629AQ37900480-80A955EF-57D2-40ED-B613-9E3E95C5A0AEQ38248845-F2C4EF02-FFA5-4875-BD7B-20560A80CA5BQ38669271-87157095-98CC-448A-8370-D6E4DEE76D06Q38850684-FD8DA9BF-155E-4611-93C0-2B832D1843E2Q38924615-F1B0FC70-0270-4E3D-8A88-AD99AE3F60E3Q38966300-421AC57B-D609-47C7-B674-4749FCBDC079Q40402499-8BA5447F-D061-4ED4-9315-CC7128341A57Q41472825-7DE0B941-7250-480A-94EA-95AA6124D750Q41884130-380D8605-0740-4C96-8CDC-DF7727D2890BQ41898776-C8EA294F-7F54-4131-8A85-05330CB63F7EQ42108095-619DA243-5A88-4C1D-AAE3-11C9EE202353Q43353829-E2FC623C-8C1D-4963-B2E7-534C5166755AQ44014290-698F9380-D7DA-438A-BE14-758607BDC4A1Q46540528-013498C4-4AA7-47A3-B0F6-A86531235A5DQ47649089-E5F82C87-B781-42AB-BE0E-F55608FDCDD3Q47799983-2EDA167D-6854-465D-8A67-7BEB37D23B2AQ49045276-1EC2446A-7718-4783-90CD-596696D19A35
P2860
Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Parkinson's disease and the gu ...... ffective cure and explanation.
@en
Parkinson's disease and the gu ...... ffective cure and explanation.
@nl
type
label
Parkinson's disease and the gu ...... ffective cure and explanation.
@en
Parkinson's disease and the gu ...... ffective cure and explanation.
@nl
altLabel
Parkinson’s disease and the gu ...... effective cure and explanation
@en
prefLabel
Parkinson's disease and the gu ...... ffective cure and explanation.
@en
Parkinson's disease and the gu ...... ffective cure and explanation.
@nl
P2860
P50
P1476
Parkinson's disease and the gu ...... ffective cure and explanation.
@en
P2860
P304
P356
10.1111/J.1365-2982.2008.01162.X
P4011
bf004bd23fe511f2e800f0f4eba6f3e7aa4793b1
P407
P577
2008-07-01T00:00:00Z